Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS · Delayed Price · Currency is USD
0.3850
-0.00252 (-0.65%)
At close: Jul 27, 2026
Elite Pharmaceuticals Market Cap
Elite Pharmaceuticals has a market cap or net worth of $414.68 million as of July 28, 2026. Its market cap has decreased by -29.83% in one year.
Market Cap
414.68M
Enterprise Value
390.70M
Revenue
148.87M
Ranking
n/a
PE Ratio
12.83
Stock Price
$0.39
ChartMarket Cap Chart
Since July 23, 1998, Elite Pharmaceuticals's market cap has increased from 9.58M to 414.68M, an increase of 4,230.78%. That is a compound annual growth rate of 14.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 414.68M | -21.27% |
| Dec 31, 2025 | 526.74M | -8.88% |
| Dec 31, 2024 | 578.04M | 306.60% |
| Dec 29, 2023 | 142.16M | 374.74% |
| Dec 30, 2022 | 29.95M | -10.40% |
| Dec 31, 2021 | 33.42M | -36.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 808.75M |
| Jushi Holdings | 79.90M |
| Sofgen Pharma | 58.35M |
| Growth Stalk Holdings | 37.71M |
| Earth Science Tech | 34.58M |
| Radnostix | 30.42M |
| High Sierra Technologies | 28.98M |
| Raphael Pharmaceutical | 28.25M |